Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members

4 affiliations
  1. 1Celularity, Florham Park, NJ, USA
  2. 2Laboratory Animal Center, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia
  3. 31Icosagen Cell Factory OÜ, Tartu, Tartumaa, Estonia
  4. 4Icosagen Cell Factory OÜ, Tartu, Tartumaa, Estonia

Related

  1. A scalable Zebrafish Platform for genetic validation and functional discovery of stage-specific breast cancer metastasis regulators
    Federica Ruscitto, Chiara Priami, Niccolò Roda +9
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textCell biologyCrossref
  2. Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
    T. Vazquez, M. Cuevas-martinez, N. Billiald +19
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  3. Targeting PRMT5 Across Cancers and AI-Driven Discovery of Candidate Compounds
    S. Rana, M. S. Hossan, A. A. Rafi +5
    bioRxivPreprintAll rights reservedFull textBioinformatics & computational biologybioRxiv
  4. Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis
    D. Patel, R. De, N. Azadi +15
    Antiviral ResearchPeer-reviewedLicence not stated3 citedMicrobiologyHAL
  5. Discovery of direct-acting small-molecule RIG-I agonists through creation of a selective CARD activation platform
    Rong Guo, Kenneisha Norford, Ling Xu +4
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
BibTeX
@article{mahlakoiv2026discoverytotherapeutics,
  title = {{211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members}},
  author = {Tanel Mahlakõiv and Nayana Gaur and Siret Tahk and Joan Teyra and Ana Shahpazir and Mart Ustav and Paule Hermet-Teesalu and Robin Pau and Kai Virumäe and Sebastian Zoll and Anu Ustav},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0211},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0211},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members
AU  - Tanel Mahlakõiv
AU  - Nayana Gaur
AU  - Siret Tahk
AU  - Joan Teyra
AU  - Ana Shahpazir
AU  - Mart Ustav
AU  - Paule Hermet-Teesalu
AU  - Robin Pau
AU  - Kai Virumäe
AU  - Sebastian Zoll
AU  - Anu Ustav
PY  - 2026
DA  - 2026/11/07
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0211
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0211
SN  - 2051-1426
ER  -